Latorre, Andrés

Andrés Latorre

+56 2 2928 2217

His practice focuses on representing Chilean and foreign clients in the acquisition and sale of public and private companies, mergers, private equity and venture capital transactions, capital markets, corporate and commercial matters.


  • Tilray, a Canadian company with a stock market capitalization of more than USD14 billion, dedicated to the production of pharmaceutical products containing medicinal cannabis, on the acquisition of Alef Biotechnology.
  • UnitedHealth Group on the acquisition of Banmédica, a Chilean healthcare company, for USD2.8 billion. Banmédica has operations in the health insurance, healthcare and medical rescue businesses, with presence in Chile, Colombia and Peru.
  • Phage Technologies, a Chilean company focused on the development of biotechnological veterinary products, on the closing of a financing round of USD4 million to open operations in Europe. Phage operates in Chile, Argentina and Brazil and distributes its product Milkeeper in association with the animal health division of Bayer. The new investors include family offices, angel investors and a Chilean venture capital fund.


  • Teaching Assistant of Roman Law, Universidad Católica de Chile (2012-2017).
  • Teaching Assistant of Procedural Law, Universidad Católica de Chile (2015-2016).
  • Law Clerk of the Corporate / Mergers & Acquisitions / Capital Markets Group, Carey (2014-2015).
  • Member of the Chilean Bar Association.


  • Law, Universidad Católica de Chile (Summa Cum Laude).
  • Outstanding Intership Award, Judicial Assistance Corporation.


  • Chile (2018).


  • Spanish.
  • English.
  • Portuguese.

© 2018 Carey   |    Disclaimer    |    Privacy and Cookie Policies

Created by Carey´s Communications and Design Department, Santiago, Chile